The Use of Canagliflozin in Diabetes Mellitus Type 2 on Renal Outcome: A Systematic Review
Introduction: One of the leading causes of death in patients with diabetes mellitus is Diabetic Kidney Disease (DKD). Canagliflozin is one of the therapeutic options that can be used to mitigate the progression of DKD. However, the limited existing studies have left the data regarding the effects of...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Faculty of Medicine, Universitas Airlangga
2024-01-01
|
| Col·lecció: | Current Internal Medicine Research and Practice Surabaya Journal |
| Matèries: | |
| Accés en línia: | https://e-journal.unair.ac.id/CIMRJ/article/view/50710 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|